ProImmune Newsletters

July 2011: Advances toward a vaccine for Ebola virus...customer applications for ProImmune's antigen characterization platform

May 2010: Discover something amazing...leading technology for epitope discovery and immunogenicity risk assessment

December 2010: A new paradigm for immunogenicity risk assessment, DC-T cell assays for evaluation of whole protein biologics

May 2009: Accelerate Your B Cell Epitope Discovery

November 2009: Breakthrough for Mouse Class II Epitope Discovery

April 2008: Systemizing Vaccine Discovery

December 2008: Reducing Immunogenicity Risk of Biologics - request printed version

December 2007: Class II MHC at the Core of Adaptive Immunity